Current Status of Gene Therapy as a New Drug Delivery System |
Bae, Yun-Sung
(College of Engineering, Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University,Microbiology Laboratory, Quality Control Department, Kyung Dong Pharm. Co. Ltd.)
Cho, Jung-Yoon (College of Engineering, Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University) Ji, Sang-Mi (College of Engineering, Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University) Lee, Young-Joo (College of Engineering, Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University) |
1 | R. Zufferey, D. Nagy, R.J. Mandel, I.Naldini and D. Trono, Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo, Nat. Biotechnol., 15, 871-875 (1997) DOI ScienceOn |
2 | T. Kafri, U. Blomer, D.A. Peterson, F.H. Gage and I.M. Verma, Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors, Nat. Genet., 17, 314-317 (1997) DOI ScienceOn |
3 | L. Naldini, U, Blomer, F.H. Gage, D, Trono and I.M. Verma, Efficient transfer, integration, and sustained long-term expre- ssion of the transgene in adult rat brains injected with a lentiviral vector, Proc. Natl. Acad. Sci. U.S.A., 93, 11382-11388 (1996) DOI ScienceOn |
4 | E. Tomlinson and A.P. Rolland, Controllable gene therapy Pharmaceutics of non-viral gene delivery systems, J. Control. Rel., 39, 357-372 (1996) DOI ScienceOn |
5 | J.P. Yang and L. Huang, Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA, Gene Ther., 4, 950-960 (1997) DOI ScienceOn |
6 | S.G. Martin amd J.C. Murray, Gene-transfer systems for human endothelial cells, Adv. Drug Deliv. Rev., 41, 223-233 (2000) DOI ScienceOn |
7 | D. Armentano, J. Zabner, C. Sacks, C.C. Sookdeo, M.P. Smith, J.A. George, S.C. Wadsworth, A.E. Smith, R.J. Gregory, Effect of the E4 region on the persistence of transgene expression from adenovirus vectors, J. Virol., 71, 2408-2416 (1997) |
8 | T. Shenk, Adenoviruses: The viruses and their replication. in Virology (Fields, B. N., et al., eds) 2111-2148, Raven Publi- shers, Philadelphia, (1996) |
9 | P.C. Ross, M.L. Hensen, R. Supabphol and S.W. Hui, Multilamellar cationic liposomes are efficient vectors for in vitro gene transfer in serum, J. Liposome Res., 8, 499-520 (1998) DOI ScienceOn |
10 | D.V. Schaffer and D.A. Lauffenburger, Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery, J. Biol. Chem., 273, 28004-28009 (1998) DOI ScienceOn |
11 | P. Schoen, L. Bijl and J. Wilschut, Efficient encapsulation of plasmid DNA in anionic liposomes by a freeze/thaw-extrusion procedure, J. Liposome Res., 8, 485-497 (1998) DOI ScienceOn |
12 | G.Y. Kao, L.J. Change and T.M. Allen, Use of targeted cationic liposomes in enhanced DNA delivery to cancer cells, Cancer Gene Ther., 3, 250-256 (1996) |
13 | R. Sipehia and G. Martucci, High-efficiency transformation of human endothelial cells by Apo E-mediated transfection with plasmid DNA, Biochem. Biophys. Res. Commun., 214, 206-211 (1995) DOI ScienceOn |
14 | C.R. Dass, T.L. Walker, M.A. Burton and E.E. Decruz, Enhan- ced anticancer therapy mediated by specialized liposomes, J. Pharm. Pharmacol., 49, 972-975 (1995) |
15 | V.L. Truong-Le, J.T. August and K.W. Leong, Controlled gene delivery by DNA-gelatin nanospheres, Hum. Gene Ther., 9, 1709-1717 (1998) DOI ScienceOn |
16 | B. Roizman, The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors, Proc. Natl. Acad. Sci. U.S.A., 93, 11307-11312 (1996) DOI ScienceOn |
17 | D.W. Losordo, P.R. Vale and J.M. Isner, Gene therapy for myocardial angiogenesis, Am. Heart J., 138, S132 (1999) DOI ScienceOn |
18 | D.J. Fink, L.R. Sternberg, P.C. Weber, M. Mata, W.F. Goins and J.C. Glorioso, In vivo expression of -galactosidase in hippocampal neurons by HSV-mediated gene transfer, Gene Ther., 3, 11-19 (1992) DOI ScienceOn |
19 | P. Yotnda, D.H. Chen, W. Chiu, P.A. Piedra, A. Davis, N.S. Templeton and M.K. Brenner, Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses, Mol. Ther., 5, 233-241 (2002) DOI ScienceOn |
20 | I. Baumgartner, A. Pieczek, O. Manor, R. Blair, M. Kearney, K. Walsh and J.M. Isner, Constitutive expression of phVEGF 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia, Circulation, 97, 1114-1123 (1998) DOI ScienceOn |
21 | M. Cavazzana-Calvo, S. Hacein-Bey, G. de Saint Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J.L. Casanova, P. Bousso, F.L. Deist and A. Fischer, Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease, Science, 288, 669 (2000) DOI |
22 | S. Li, M.A. Rizzo, S. Bhattacharya and L. Huang, Charac-terization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery, Gene Ther., 5, 930-937 (1998) DOI ScienceOn |
23 | K.W. Peng, Strategies for targeting therapeutic gene delivery, Mol. Med. Today, 5, 448-458 (1999) DOI ScienceOn |
24 | S. Li, W.C. Tseng, D.B. Stolz, S.P. Wu, S.C. Watkins and L. Huang, Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection, Gene Ther., 6, 585-594 (1999) DOI ScienceOn |
25 | H.Q. Mao, K. Roy, V.L. Troung-Le, K.A. Janes, K.Y. Lin, Y. Wang, J.T. August and K.W. Leong, Chitosan-DNA nano- particles as gene carriers: synthesis, characterization and transfection efficiency, J. Control. Rel., 70, 399-421 (2001) DOI ScienceOn |
26 | F.C. MacLaughlin, R.J. Mumper, J. Wang, J.M. Tagliaferri, I. Gill, M. Hinchcliffe and A.P. Rolland, Chitosan and depoly- merized chitosan oligomers as condensing carriers for in vivo plasmid delivery, J. Control. Rel., 56, 259-272 (1998) DOI ScienceOn |
27 | J. Smith, Y. Zhang and R. Niven, Toward development of a non-viral gene therapeutic, Adv. Drug Deliver. Rev., 26, 135-150 (1997) DOI ScienceOn |
28 | M. Nishikawa and L. Huang, Nonviral vectors in the new millennium: Delivery barriers in gene transfer, Hum. Gene Ther., 12, 861-870 (2001) DOI ScienceOn |
29 | The Journal of Gene Medicine website (http://www.wiley. co.uk/genetherapy), Wiley |
30 | K.R. Clark, X. Liu, J.P. McGrath and P.R. Johnson, Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses, Hum. Gene Ther., 10, 1031-1039 (1999) DOI ScienceOn |
31 | G.J. Nabel, E.G. Nabel, Z.Y. Yang, B.A. Fox, G.E. Plautz, X. Gao, L. Hung, S. Shu, D. Gordon and A.E. Chang, Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biological activity, and lack of toxicity in humans, Pro. Natl. Acad. Sci. U.S.A., 90, 11307-11311 (1993) DOI ScienceOn |
32 | A. Pfeifer and I.M. Verma, Gene therapy: Promises and Problems, Annu. Rev. Genomics Hum. Genet., 2, 177-211 (2001) DOI ScienceOn |
33 | W.J. Choi and C.K. Kim, Recent advance and future strategy in gene delivery system, J. Kor. Pharm. Sci., 30, 1-12 (2000) |
34 | I.M. Verma and N. Somia, Gene therapy-promises, problems and prospects, Nature, 389, 239-242 (1997) DOI ScienceOn |
35 | W.F. Anderson, Human gene therapy, Nature, 392, 25s (1998) DOI ScienceOn |
36 | C. Plank, K. Mechtler, F.C. Szoka and E. Wagner, Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery, Hum. Gene Ther., 7, 1437-1446 (1996) DOI ScienceOn |
37 | N. Chirmule, K. Propert, S. Magosin, Y. Qian, R. Qian and J. Wilson, Immune responses to adenovirus and adeno-associated virus in humans, Gene Ther., 6, 1574-1583 (1999) DOI ScienceOn |
38 | N. Muzyczka, Use of adeno-associated virus as a general transduction vector for mammalian cells, Curr. Top. Microbiol. Immunol., 158, 97-129 (1992) DOI |
39 | G.L. Clayman, A.K. el-Naggar, S.M. Lippman, Y.C. Hen- derson, M. Frederick, J.A. Merritt, L.A. Zumstein, T.M. Timmons, T.J. Liu, L. Ginsberg, J.A. Roth, W.K. Hong, P. Bruso and H. Goepfert, Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma, J. Clin. Oncol., 16, 2221-2232 (1998) DOI |
40 | J. Nemunaitis, S.G. Swisher, T. Timmons, D. Connors, M. Mack, L. Doerksen, D. Weill, J. Wait, D.D. Lawrence, B.L. Kemp, F. Fossella, B.S. Glisson, W.K. Hong, F.R. Khuri, J.M. Kurie, J.J. Lee, J.S. Lee, D.M. Nguyen, J.C. Nesbitt, R. Perez-Soler, K.M. Pisters, J.B. Putnam, W.R. Richli, D.M. Shin, G.L. Walsh, J. Merritt and J. Roth, Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer, J. Clin. Oncol., 18, 609-622 (2000) DOI |
41 | M.G. Kaplitt, P. Leone, R.J. Samulski, X. Xiao, D.W. Pfaff, K.L. O'Malley and M.J. During, Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain, Nature Genet., 8, 148-154 (1994) DOI ScienceOn |
42 | R.M. Blease, K.W. Culver, A.D. Miller, C.S. Carter, T. Fleisher, M. Clerici, G. Shearer, L. Chang, Y. Chiang, P. Tolstoshev, J.J. Greenblatt, S.A. Rosenberg, H. Klein, M. Berger, C.A. Mullen, W.J. Ramsey, L. Muul, R.A. Morgan and W.F. Anderson, T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years, Science, 270, 475-480 (1995) DOI ScienceOn |
43 | J.C. Glorioso, W.F. Goins and D.J. Fink, Herpes simplex virus-based vectors, Semin. Virol., 3, 265-276 (1992) |